AI Chatbot Evaluation for Painful Diabetic Peripheral Neuropathy Patient Advice — Five-Platform Comparison
COMPARISONA comparative evaluation assessed five generative AI chatbots on their performance providing patient-oriented advice about painful diabetic peripheral neuropathy (painful DPN) — a condition requiring careful management of medication, foot care, and specialist referral. Platforms were evaluated across dimensions of safety, accuracy, guideline concordance, actionability, and readability. Results revealed distinct performance patterns across platforms, with no single chatbot dominating across all dimensions. Notably, despite no statistically significant overall safety difference between systems, every platform produced at least one response containing a plausible pathway to harm. Identified harm pathways included guidance that could lead to inappropriate self-management, delayed medical assessment, medication or product misuse, or preventable injury — all clinically significant risks in a population already at elevated risk for serious complications including foot ulceration and amputation. The authors conclude that chatbots may appropriately support general patient education about painful DPN but should not be relied upon for medication decisions, foot-risk assessment, or urgent-care triage without professional verification. The study contributes to evidence that AI chatbot safety in patient-facing applications is domain-dependent and that even systems performing well on average can generate dangerous outlier responses. These findings argue for condition-specific safety…
Subscribe to read full wiki analysis
Full wiki content — including source provenance, contradiction tracking, related pages, and analyst notes — is available to Subscriber members.
View Plans & SubscribeNew users get a 7-day trial — no credit card required.